Kiadis Pharma NV (LTS:0RBP) Long-Term Debt : €0.00 Mil (As of Dec. 2020)

View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Long-Term Debt?

Kiadis Pharma NV's Long-Term Debt for the quarter that ended in Dec. 2020 was €0.00 Mil.

Kiadis Pharma NV's quarterly Long-Term Debt increased from Dec. 2019 (€0.91 Mil) to Jun. 2020 (€0.93 Mil) but then declined from Jun. 2020 (€0.93 Mil) to Dec. 2020 (€0.00 Mil).

Kiadis Pharma NV's annual Long-Term Debt declined from Dec. 2018 (€21.84 Mil) to Dec. 2019 (€0.91 Mil) and declined from Dec. 2019 (€0.91 Mil) to Dec. 2020 (€0.00 Mil).

Kiadis Pharma NV Long-Term Debt Historical Data

The historical data trend for Kiadis Pharma NV's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Long-Term Debt Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Long-Term Debt

Get a 7-Day Free Trial

15.61

21.60

21.84

0.91

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Long-Term Debt	Get a 7-Day Free Trial											21.84	15.83	0.91	0.93	-

Kiadis Pharma NV (LTS:0RBP) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Kiadis Pharma NV Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (LTS:0RBP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (LTS:0RBP) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (LTS:0RBP) Headlines

No Headlines